Lv4
460 积分 2022-11-14 加入
Quality of life outcomes for patients with metastatic castration‐resistant prostate cancer and pretreatment prognostic score
6天前
已完结
Treatment Response Imaging in Prostate Cancer
26天前
已完结
Prediction of Progression Following Radical Prostatectomy
1个月前
已关闭
First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen–targeted Probe for Preoperative Positron Emission Tomography/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer
1个月前
已完结
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial
2个月前
已完结
Renal and Multiorgan Safety of177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
2个月前
已完结
Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer
2个月前
已关闭
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial
2个月前
已完结
Comparative outcomes of multi-port versus single-port robotic-assisted partial nephrectomy with same-day discharge: impact of surgical approach
2个月前
已完结
Situation with cancer care in Russia. Kidney cancer (median survival, cumulative survival, and survival of patients depending on their disease stage). Population-based study at the federal district level. Part 2
2个月前
已完结
皖公网安备34019202002308
